<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Basic fibroblast growth factor is a <z:chebi fb="1" ids="15841">polypeptide</z:chebi> with potent multipotential trophic effects on central <z:mp ids='MP_0008912'>nervous</z:mp> system cells, including neurons, glia, and endothelial cells </plain></SENT>
<SENT sid="1" pm="."><plain>In particular, it promotes the survival of a wide variety of brain neurons in vitro, and protects these neurons against the effects of several neurotoxins, including excitatory amino acids, <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, and <z:chebi fb="0" ids="22986">calcium ionophore</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Since lack of substrate delivery, excitatory amino acid toxicity, and calcium entry into cells appear to be important processes in neuronal <z:hpo ids='HP_0011420'>death</z:hpo> after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, we tested the hypothesis that pretreatment with basic fibroblast growth factor limits <z:mpath ids='MPATH_124'>infarct</z:mpath> size in a model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>Mature male Long-Evans rats received either continuous intraventricular infusion of basic fibroblast growth factor (1.2 micrograms/day; with or without <z:chebi fb="5" ids="28304">heparin</z:chebi>, added to stabilize the growth factor) or vehicle alone for 3 days before focal ischemic <z:mpath ids='MPATH_124'>infarcts</z:mpath> were made in the right lateral cerebral cortex by permanent distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and temporary (45-minute) bilateral carotid occlusion </plain></SENT>
<SENT sid="4" pm="."><plain>Intraoperative measurements of core temperature, arterial blood pressure and blood gases, blood <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration, and hematocrit, and postoperative measurements of temperature revealed no differences among vehicle- versus basic fibroblast growth factor-treated animals </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-four hours later, animals were killed, brains were removed and stained to visualize cortical <z:mpath ids='MPATH_124'>infarcts</z:mpath>, and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was determined by image analysis </plain></SENT>
<SENT sid="6" pm="."><plain>Overall, we found a 25% reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in basic fibroblast growth factor- (N = 25) versus vehicle-treated (N = 23) animals (p &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>This reduction was not enhanced by the addition of <z:chebi fb="5" ids="28304">heparin</z:chebi>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>